Brain Tumor, Primary: Clinical Trials

4 trials for Brain Tumor, Primary, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown, 1 withdrawn. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 11Recruiting 1

Follow Brain Tumor, Primary: new trials by email Literature Review of Brain Tumor, Primary trials Research Report on Brain Tumor, Primary

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
RVP-001 - Central Nervous System (CNS) Lesions, Brain Metastases
Phase 2CompletedReveal Pharmaceuticals Inc.182024-08-152025-12-26
The Efficacy of HLX208 (BRAF V600E Inhibitor) for Refractory Primary Brain Tumors With BRAF Mutation After First-line Treatment
HLX208 - Brain Tumor, Primary
Phase 2UnknownShanghai Henlius Biotech402021-12-232022-05-03
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
Capecitabine, Temozolomide - Glioblastoma Multiforme (GBM), Glioblastoma
Phase 1 / Phase 2RecruitingNorthwell Health672017-06-132026-06-01
More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
5-ALA (Gliolan) - Benign Neoplasms, Brain, Brain Cancer
Phase 2WithdrawnConstantinos Hadjipanayis2015-11-012016-05-17

Narrower conditions

Brain Neoplasms (4)  ·  Glioblastoma (2)  ·  Glioma (2)  ·  Neoplasms (2)  ·  Central Nervous System Neoplasms (1)  ·  Meningioma (1)  ·  Multiple Sclerosis (1)  ·  Neurilemmoma (1)  ·  Neurofibroma (1)  ·  Neuroinflammatory Diseases (1)  ·  Neuroma, Acoustic (1)

Broader conditions

Brain Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Neoplasms by Site (4)  ·  Nervous System Diseases (4)  ·  Nervous System Neoplasms (4)  ·  Central Nervous System Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Germ Cell and Embryonal (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Neoplasms, Neuroepithelial (3)  ·  Neuroectodermal Tumors (3)  ·  Astrocytoma (2)  ·  Neoplasms (2)  ·  Autoimmune Diseases (1)

Interventions

Aminolevulinic Acid (1)  ·  Capecitabine (1)  ·  Mn-PyC3A (1)  ·  Temozolomide (1)

Sponsors

Constantinos Hadjipanayis (1)  ·  Northwell Health (1)  ·  Reveal Pharmaceuticals Inc. (1)  ·  Shanghai Henlius Biotech (1)

Countries

United States (3)  ·  China (1)

Top investigators

Costas Hadjipanayis, MD, PhD (1)  ·  Jinming Yu (1)  ·  John Boockvar, MD (1)

NIH funding

R01CA176659 (1), R21CA186169 (1), R44CA261240 (1)